Marcello Cottini
Bergamo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Impact and management of biologic therapies on small airway dysfunction in severe asthma: a comprehensive review.
Journal: Expert review of respiratory medicine
Published: August 31, 2026
Dual REmission in moderate-to-severe AsthMa and nasal polyps: a multicentric observational phase IV real-life study (DREAM-NP).
Journal: Expert opinion on biological therapy
Published: July 24, 2026
Improved peripheral airway reactance is associated with clinical remission following biologic therapy in severe asthma.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: June 11, 2026
Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study.
Journal: Expert opinion on biological therapy
Published: May 27, 2026
Combined large and small airway obstruction is associated with increased exacerbation frequency and poorer symptom control in persistent asthma.
Journal: The journal of allergy and clinical immunology. In practice
Published: May 09, 2026
Small Airways Disease predicts exacerbation risk in well-controlled, but not in poorly-controlled asthma: a post-hoc analysis of the ATLANTIS study.
Journal: The journal of allergy and clinical immunology. In practice
Published: May 08, 2026
Small airway dysfunction: a key predictor of exacerbation risk in adolescents with mild, well-controlled asthma.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: April 14, 2026
Dual Remission in Patients with Moderate-to-Severe Asthma and CRSwNP Treated with Dupilumab: A 24-Month Real-World Study.
Journal: Journal of clinical medicine
Published: February 21, 2026
Small Airway Dysfunction May Mediate the Association Between Body Mass Index and Severe Asthma Exacerbations.
Journal: The European respiratory journal
Published: January 20, 2026
The convergent pathway of obstructive lung disease: the disease-modifying potential of dipeptidyl peptidase 1 inhibition in COPD, asthma and bronchiectasis overlap.
Journal: Drugs in context
Published: November 27, 2025
Unraveling the obesity-asthma link: A new horizon with glucagon-like peptide-1 receptor agonists in a complex intersection of metabolism and airway disease.
Journal: The Journal of international medical research
Published: November 05, 2025
Mucus Plugs as a Structural Treatable Trait in Asthma: Lessons From IL-5 Inhibition.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 26, 2025
Last Updated: 09/26/2026